Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9268 |
High Similarity |
NPD422 |
Phase 1 |
0.8864 |
High Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8864 |
High Similarity |
NPD5124 |
Phase 1 |
0.864 |
High Similarity |
NPD1548 |
Phase 1 |
0.8636 |
High Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8538 |
High Similarity |
NPD2797 |
Approved |
0.8496 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8489 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8485 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8462 |
Intermediate Similarity |
NPD3225 |
Approved |
0.838 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8372 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8358 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8306 |
Intermediate Similarity |
NPD5535 |
Approved |
0.8284 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8252 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8209 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.8163 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8156 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.8129 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8099 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8088 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8074 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8014 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7985 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7985 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7971 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.797 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7958 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7933 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7872 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7872 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7852 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7842 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7842 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7842 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7817 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7817 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7817 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7815 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7803 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7786 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7763 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7733 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.773 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7718 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7708 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7698 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7698 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7687 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7687 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7662 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7651 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7642 |
Intermediate Similarity |
NPD940 |
Approved |
0.7642 |
Intermediate Similarity |
NPD846 |
Approved |
0.7635 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.763 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7626 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7616 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7612 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7609 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7594 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7589 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7582 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7569 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7569 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7562 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7556 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7554 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD920 |
Approved |
0.7532 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1934 |
Approved |
0.75 |
Intermediate Similarity |
NPD1608 |
Approved |
0.75 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7481 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7445 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7424 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7413 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7402 |
Intermediate Similarity |
NPD3134 |
Approved |
0.74 |
Intermediate Similarity |
NPD2532 |
Approved |
0.74 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD2534 |
Approved |
0.74 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7388 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7343 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7329 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7324 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7319 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7319 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7297 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7287 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7286 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD17 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7279 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7279 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7279 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD6502 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD968 |
Approved |
0.7261 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7248 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7236 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7236 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7234 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7192 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7192 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7192 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7179 |
Intermediate Similarity |
NPD37 |
Approved |
0.7178 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD919 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7163 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7162 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7162 |
Intermediate Similarity |
NPD5762 |
Approved |
0.716 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7154 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7154 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7153 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7143 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7134 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD5163 |
Phase 2 |
0.7132 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7124 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7095
|
Intermediate Similarity |
NPD2862 |
Discontinued |